Skip to Content

Workers’ Compensation Board

Search menu

Save the Date – COVID-19 and Workers’ Compensation Webinar

Subject Number 046-643 Temporary Suspension of Dr. John Buckley's Authorization to Treat Injured Workers Effective October 15, 2013

Subject Numbers Regarding Health Provider Authorizations

Authorization No. 159965-3W

October 23, 2013

Pursuant to Workers' Compensation Law Section 13-d(4), the Chair of the New York State Workers' Compensation Board has exercised his authority to temporarily suspend Dr. John Buckley's authorization to treat injured workers within the New York State workers' compensation system effective October 15, 2013. Dr. Buckley's last known business address is 2300 Buffalo Road, Building 900, Suite B, Rochester, NY 14624.

The Chair's designee's investigation has revealed that the Department of Health, Bureau of Professional Medical Conduct (BPMC) has issued BPMC Order # 13-274, wherein, Dr. Buckley did not contest the charge of negligence on more than one occasion. As a result, his license has been suspended for 60 months, stayed with probation for 60 months. His license is also permanently limited, precluding him from prescribing for patients controlled substances beyond a single 30 day period. Patients requiring a controlled substance for pain management beyond a 30 day period must be referred to a pain management specialist. All prescriptions for controlled substances for pain management must be reviewed and approved within 72 hours by the Director of the University of Rochester's Center for Primary Care. Therefore, the Chair believes that Dr. Buckley may be guilty of misconduct.

Dr. Buckley is prohibited from rendering treatment and care to injured workers while his authorization is temporarily suspended. Reports submitted by Dr. Buckley for services rendered prior to October 15, 2013, are valid, but are invalid for any services rendered on or after that date. Requests to cross-examine Dr. Buckley for services rendered prior to October 15, 2013 should not be denied due to the suspension of his authorization.

This suspension remains in effect until further notice. Any questions regarding the authorized lists should be referred to the Medical Director's Office at 1 (800) 781-2362.

Robert E. Beloten